Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

Published:2023-02 Issue:2 Volume:26 Page:193-203
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Huygens Simone,Vellekoop Heleen,Versteegh Matthijs,Santi Irene,Szilberhorn László,Zelei Tamás,Nagy Balázs,Tsiachristas Apostolos,Koleva-Kolarova Rositsa,Wordsworth Sarah,Rutten-van Mölken Maureen

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference35 articles.

1. Efficacy of larotrectinib in TRK fusion–positive cancers in adults and children;Drilon;N Engl J Med,2018

2. Larotrectinib in patients with TRK fusion-positive solid tumors: a pooled analysis of three phase 1/2 clinical trials;Hong;Lancet Oncol,2020

3. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumors: integrated analysis of three phase 1-2 trials;Doebele;Lancet Oncol,2020

4. Exploring heterogeneity in histology-independent technologies and the implications for cost-effectiveness;Murphy;Med Decis Mak,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the Comparator in Your Diagnostic Cost-Effectiveness Model “Standard of Care”? Recommendations from Literature Reviews and Expert Interviews on How to Identify and Operationalize It;Value in Health;2024-05

2. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands;Molecular Diagnosis & Therapy;2024-04-14

3. Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions;Value in Health;2023-11

4. Graphene Oxide Nanostructures as Nanoplatforms for Delivering Natural Therapeutic Agents: Applications in Cancer Treatment, Bacterial Infections, and Bone Regeneration Medicine;Nanomaterials;2023-09-28

5. Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples;International Journal of Molecular Sciences;2023-09-17